Aprea Therapeutics (APRE) Insider Trading & Ownership $2.09 -0.11 (-5.00%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$2.10 +0.01 (+0.48%) As of 03/28/2025 05:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aprea Therapeutics (NASDAQ:APRE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.80%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$165,095.70Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$29,595.96 Get APRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APRE Insider Buying and Selling by Quarter Remove Ads Aprea Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/23/2024Oren GiladCEOBuy500$3.92$1,960.00 10/18/2024Marc DueyDirectorSell6,462$4.58$29,595.96 10/16/2024Marc DueyDirectorBuy30,000$4.39$131,700.00 10/14/2024Marc DueyDirectorBuy190$2.58$490.20 10/14/2024Oren GiladCEOBuy1,000$2.59$2,590.00 10/11/2024Bernd R SeizingerDirectorBuy10,000$2.68$26,800.00 10/10/2024John P HamillCFOBuy450$2.61$1,174.50 10/10/2024Oren GiladCEOBuy150$2.54$381.00 (Data available from 1/1/2013 forward) APRE Insider Trading Activity - Frequently Asked Questions Who is on Aprea Therapeutics's Insider Roster? The list of insiders at Aprea Therapeutics includes Bernd R Seizinger, John P Hamill, Marc Duey, and Oren Gilad. Learn more on insiders at APRE. What percentage of Aprea Therapeutics stock is owned by insiders? 12.80% of Aprea Therapeutics stock is owned by insiders. Learn more on APRE's insider holdings. Which Aprea Therapeutics insiders have been buying company stock? The following insiders have purchased APRE shares in the last 24 months: Bernd R Seizinger ($91,576.24), John P Hamill ($8,537.40), Marc Duey ($132,190.20), and Oren Gilad ($19,511.00). How much insider buying is happening at Aprea Therapeutics? Insiders have purchased a total of 56,228 APRE shares in the last 24 months for a total of $251,814.84 bought. Which Aprea Therapeutics insiders have been selling company stock? The following insider sold APRE shares in the last 24 months: Marc Duey ($29,595.96). How much insider selling is happening at Aprea Therapeutics? Insiders have sold a total of 6,462 Aprea Therapeutics shares in the last 24 months for a total of $29,595.96 sold. Aprea Therapeutics Key ExecutivesDr. Oren Gilad Ph.D. (Age 56)Co-Founder, CEO, President & Director Compensation: $796.95kMr. John P. Hamill CPA (Age 60)Senior VP, CFO, Principal Accounting Officer & Secretary Compensation: $610.23k1 recent tradesDr. Dansu Li Ph.D.Head of TechnologyDr. Lars B. Abrahmsen Ph.D. (Age 67)Senior VP & Chief Scientific Officer Mr. Brian Wiley (Age 56)Senior Vice President of Corporate Development & Strategy Dr. Michel Afargan Ph.D.Head of Pharmacology DevelopmentMr. Ze'ev Weiss B.Sc. (Age 62)C.P.A., Chief Business Advisor Dr. Nadeem Q. Mirza M.D.M.P.H., Chief Medical OfficerMs. Andrea EpsteinController More Insider Trading Tools from MarketBeat Related Companies OKYO Insider Trading VRCA Insider Trading OTLK Insider Trading RPTX Insider Trading IBIO Insider Trading NBRV Insider Trading KZR Insider Trading SPRO Insider Trading CELU Insider Trading DTIL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:APRE) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
